Is it Time to Reappraise for Black-Box Warning on AngioJet Rheolytic Thrombectomy in Patients with Pulmonary Embolism: A Systematic Review and Meta-analysis
Authors:
- Cihangir KaymazCKCihangir Kaymaz
- Barkın KültürsayBKBarkın Kültürsay
- Hacer Ceren TokgözHTHacer Ceren Tokgöz
- Aykun HakgörAHAykun Hakgör
- Berhan KeskinBKBerhan Keskin
- Özgür Yaşar AkbalÖAÖzgür Yaşar Akbal
- Ayhan TosunATAyhan Tosun
- Seda TanyeriSTSeda Tanyeri
- Ahmet SekbanASAhmet Sekban
- Çağdaş BuluşÇBÇağdaş Buluş
- Şeyhmus KülahçıoğluŞKŞeyhmus Külahçıoğlu
- Ali KaragözAKAli Karagöz
Open Access
- 1 January 2024
- journal article
- review article
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 28 (6) , 264-272
Abstract
Background: AngioJet rheolytic thrombectomy (ART) system has been widely used as a catheter-directed treatment (CDT) method in acute pulmonary embolism (PE), however, there has been a controversy regarding the safety of its use. In this systematic review and meta-analysis, we evaluated the efficacy and safety outcomes of ART in patients with PE. Methods: Our meta-analysis have been based on search in the MEDLINE, EMBASE, and Cochrane Library for studies published up to August 2022. The primary outcomes were overall pooled rates of major bleeding (MB) and minor bleeding (mB), worsening renal function (WRF), bradycardia/conduction disturbance (BCD), and PE-related and all- cause mortality in patients who underwent ART. Results: Among the 233 studies documented at initial search, 24 studies were eligible for meta-analysis, and a total of 427 PE patients who underwent ART were evaluated. Overall pooled rates of MB and mB were 9.6% (95% CI 5.9%-15.2%) and 9.2% (95% CI 6.1%13.6%), transient BCD and WRF were 18.2% (95% CI 12.4%-26%) and 15% (95% CI 10%21.8%), and PE-related death and all-cause death were 12.7% (95% CI 9.1%-17.3%) and 15% (95% CI 11%-20%), respectively. However, significant heterogeneity and some evidence of funnel plot asymmetry and publication bias were noted for MB, BCD and WRF, but not for PE-related death and all-cause death. Conclusion: Overall pooled rates of bleeding events, BCD and WRF episodes, PE-related death and all-cause death may be considered as encouraging results for efficacy and safety issues of ART utilization in specific scenarios of acute PE, and a reappraisal for black-box warning on ART seems to be necessary.Keywords
This publication has 45 references indexed in Scilit:
- Acute kidney injury caused by intravascular hemolysis after mechanical thrombectomyNature Clinical Practice Nephrology, 2008
- Percutaneous Mechanical Thrombectomy for Massive Pulmonary Embolism Using a Conservative Treatment StrategyJournal of Interventional Cardiology, 2008
- Early and Long-Term Clinical Results of AngioJet Rheolytic Thrombectomy in Patients With Acute Pulmonary EmbolismThe American Journal of Cardiology, 2008
- Percutaneous rheolytic thrombectomy for large pulmonary embolism: A promising treatment optionCatheterization and Cardiovascular Interventions, 2007
- Bradyarrhythmias During Use of the AngioJet SystemJournal of Vascular and Interventional Radiology, 2006
- AngioJet Rheolytic Thrombectomy Versus Local Intrapulmonary Thrombolysis in Massive Pulmonary Embolism:A Retrospective Data AnalysisJournal of Endovascular Therapy, 2005
- Use of Rheolytic Thrombectomy in Treatment of Acute Massive Pulmonary EmbolismJournal of Vascular and Interventional Radiology, 2003
- Clinical application of a new rheolytic thrombectomy catheter system for massive pulmonary embolismCatheterization and Cardiovascular Interventions, 1999
- A New Treatment for Severe Pulmonary EmbolismCirculation, 1997
- Transvenous Pulmonary Embolectomy by Catheter DeviceAnnals of Surgery, 1971